IRIS
DI NISIO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.029
EU - Europa 3.453
AS - Asia 2.267
SA - Sud America 84
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 10.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.004
SG - Singapore 887
CN - Cina 807
IE - Irlanda 769
UA - Ucraina 612
SE - Svezia 522
IT - Italia 436
TR - Turchia 406
GB - Regno Unito 262
DE - Germania 235
FR - Francia 179
FI - Finlandia 166
RU - Federazione Russa 142
BR - Brasile 74
IN - India 59
AT - Austria 32
VN - Vietnam 31
BE - Belgio 25
TW - Taiwan 23
NL - Olanda 21
CA - Canada 20
ES - Italia 14
CZ - Repubblica Ceca 13
EU - Europa 12
AU - Australia 10
IR - Iran 7
HK - Hong Kong 6
IL - Israele 6
KR - Corea 6
TH - Thailandia 6
ID - Indonesia 5
JP - Giappone 5
RO - Romania 5
AR - Argentina 4
EG - Egitto 3
HR - Croazia 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
DK - Danimarca 2
EE - Estonia 2
GR - Grecia 2
HU - Ungheria 2
LT - Lituania 2
MY - Malesia 2
SR - Suriname 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
TG - Togo 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 10.871
Salva come PNG Salva come JPEG
Città #
Chandler 1.002
Jacksonville 861
Dublin 758
Singapore 574
Princeton 393
Izmir 270
Ashburn 226
Nanjing 214
Altamura 184
Southend 177
Wilmington 168
Santa Clara 140
Cambridge 137
Dearborn 132
Beijing 126
Boardman 90
Ann Arbor 83
Nanchang 71
Woodbridge 68
Helsinki 62
Chieti 61
Houston 58
Los Angeles 56
Hebei 46
Kunming 46
Shenyang 36
Tianjin 36
Washington 36
Jiaxing 34
Dong Ket 31
Seattle 29
Pescara 26
Changsha 25
Vienna 24
Brussels 23
Norwalk 22
New York 21
Nuremberg 20
Guangzhou 17
Hangzhou 17
Fairfield 14
Falls Church 13
Leawood 13
Munich 13
Pune 13
Taipei 12
Grevenbroich 11
Olomouc 11
Hefei 10
San Mateo 10
Edinburgh 9
Shanghai 9
Changchun 8
Jinan 8
Madrid 8
Romola 8
Sydney 8
Ardabil 7
Hanover 7
Moscow 7
Orange 7
Amsterdam 6
Augusta 6
Bangkok 6
Milan 6
Mountain View 6
Suresnes 6
Teramo 6
Cheyenne 5
Frankfurt am Main 5
Redwood City 5
Rochester 5
Rome 5
Saint Louis 5
São Paulo 5
Zhengzhou 5
Auburn Hills 4
Clifton 4
Des Moines 4
Florence 4
Hong Kong 4
Lanzhou 4
Lappeenranta 4
London 4
Monmouth Junction 4
Mumbai 4
New Taipei 4
Ningbo 4
Paris 4
Plymouth 4
San Antonio 4
Seveso 4
Stockholm 4
Tappahannock 4
Toronto 4
Alba Adriatica 3
Andover 3
Bucharest 3
Gangbuk-gu 3
Istanbul 3
Totale 6.779
Salva come PNG Salva come JPEG
Nome #
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 199
Supportive management strategies for disseminated intravascular coagulation: An international consensus 132
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 116
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 112
Treatment of Lower Extremity Superficial Thrombophlebitis 99
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 97
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 90
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 88
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 87
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 86
Circulating leptin is associated with oxidized LDL in postmenopausal women. 85
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 85
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 83
The hematocrit and platelet target in polycytemia vera 80
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 80
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 80
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 79
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 79
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 78
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 78
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 78
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 77
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 77
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 77
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 76
Non-O blood group and outcomes of in vitro fertilization 76
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 75
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 75
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 75
Rivaroxaban for cancer-associated cardiac thrombosis 75
Antithrombotic therapy and cancer 74
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 74
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 74
Improving the diagnostic management of upper extremity deep vein thrombosis 73
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 73
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 71
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 71
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 71
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 70
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 70
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 70
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 70
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 70
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 69
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 69
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 68
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 68
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 68
Effects of body composition on the procoagulant imbalance in obese patients 68
D-Dimer test in cancer patients with suspected acute pulmonary embolism 68
Superior vena cava syndrome from an intracardiac non-Hodgkin lymphoma. 66
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 66
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and symptomatic pulmonary embolism: a systematic review 66
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 66
The SISET incorrectly cited the JAAM DIC scoring system 65
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 65
Decision analysis for cancer screening in idiopathic venous thromboembolism 65
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 65
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 65
Treatment for superficial infusion thrombophlebitis of the upper extremity. 64
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 64
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 64
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 64
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 64
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery. 63
Deep vein thrombosis and pulmonary embolism 63
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 63
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 63
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 63
Edoxaban for the treatment of cancer-associated venous thromboembolism 63
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 63
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 63
Cell-derived microvesicles and cancer 62
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 62
Cannabinoids for medical use: A systematic review and meta-analysis 62
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 62
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 62
Splanchnic vein thrombosis: Current perspectives 62
Pravastatin-dependent TGF-β1 effect on scavenger receptor class A expression in THP-1 human macrophages 62
Plasma cytokines and P-selectin levels in advanced malignancy: prognostic value and impact of low-molecular-weight heparin administration 61
Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: A systematic review 61
Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH 61
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 61
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: Guidance from the SSC of the ISTH 61
Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study 60
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 60
Cancer-associated unsuspected pulmonary embolism 60
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 60
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 60
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 60
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 59
Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome 59
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 59
Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients 59
Inhaled analgesia for pain management in labour 59
Low molecular-weight heparins improve the survival of cancer patients? 58
Treatment for superficial thrombophlebitis of the leg 58
Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? 58
Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment 58
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer 57
Totale 7.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.668
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020414 0 0 0 0 0 0 0 0 43 157 192 22
2020/2021980 127 20 278 27 72 228 10 9 12 68 50 79
2021/2022758 10 10 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20251.837 200 619 402 63 52 98 76 250 77 0 0 0
Totale 11.576